Release – V2X (Formerly Vectrus) Reports Strong Second Quarter 2022 Results



V2X (Formerly Vectrus) Reports Strong Second Quarter 2022 Results

Research, News, and Market Data on V2X

Company Release – 
8/9/2022

Important Note: On July 5, 2022, Vectrus, Inc. closed on the
merger with The Vertex Company (“the Transaction”) and in connection
with the closing was renamed V2X, Inc. “Reported results” reflect the
contributions of Vectrus, Inc. based on results prior to the close of the
Transaction, unless otherwise noted.

Vectrus Second Quarter Highlights:

  • Second quarter revenues of $498 million, up +6% Y/Y
  • Operating income (inclusive of V2X transaction expenses) of $15.0 million with a margin of 3.0%
  • Adjusted EBITDA1 of $24.7 million with a margin of 5.0%
  • Second quarter fully diluted EPS of $0.88; Adjusted diluted EPS1 of $1.41
  • Strong second quarter operating cash flow of $46 million

Guidance:

  • The V2X merger closed on July 5, 2022, creating a more diversified company generating approximately $3.6 billion in combined pro forma annual revenue
  • Establishing second-half 2022 guidance for V2X that reflects the contributions of both Vectrus and Vertex with a total revenue range of $1.90 to $1.94 billion, an Adjusted EBITDA1 range of $140 to $150 million, and an operating cash flow range of $130 to $150 million

MCLEAN, Va., Aug. 9, 2022 /PRNewswire/ — V2X, Inc. (NYSE:VVX) announced second quarter 2022 financial results. The second quarter 2022 results are based on Vectrus’ stand-alone financial metrics for the period ended July 1, 2022, and do not include contribution from The Vertex Company.

V2X (PRNewsfoto/V2X, Inc.)

Transaction
Update

“We’re excited to announce the successful combination of Vectrus and The Vertex Company, creating a larger, higher margin and more diversified, V2X,” said Chuck Prow, Chief Executive Officer of V2X.  “With 14,000 employees, $3.6 billion in pro forma annual revenue, and $290 million of Adjusted EBITDA, V2X is a leader in the operational segment of the federal services market providing converged solutions throughout the mission lifecycle of our clients most critical and enduring global missions.”

Prow continued, “V2X has a strong financial profile with significant free cash flow and long-term revenue visibility through several notable contract wins that are in the early stages of their lifecycle. These wins are reflected in the company’s trailing twelve-month awards of approximately $6 billion, which include two recent significant awards at Vertex, the Naval Test Wing Atlantic, a seven-year program valued at $850 million, and the Air Force Global Strike Command five-year contract valued at $130 million. This also includes $600 million of awards booked at Vectrus during the quarter that were driven by expansion and increased scope on existing programs as well as follow-on contracts. The strong velocity of awards has resulted in a significant backlog of approximately $12 billion that provides solid visibility over the next several years.”

“In summary, the financial and strategic attributes of V2X are compelling,” added Prow. “Our integration activities are well underway and the commitment to our clients, the missions we are privileged to support, and delivering results remains our focus.”

Vectrus
Second Quarter Results

“Second quarter results for stand-alone Vectrus were strong, propelled by top-line performance and favorable operating cash flow,” said Prow.  “During the quarter, revenue grew 6% year-over-year and 9% sequentially to $498 million. Revenue growth was driven by building on the momentum of programs in INDOPACOM and Europe, along with successful phase-in of new contracts, including the Logistics Readiness Center at Fort Benning,” said Prow.  “Each day, our global team of dedicated employees execute on our core programs while also bringing innovation and technology-oriented solutions to complex challenges throughout the mission lifecycle.”  

“With a high-level readiness to meet the needs of our clients, the team continued its support of several important missions during the quarter, including providing the DoD with urgent and compelling services for the European Deterrence Initiative,” said Prow. “We leveraged our rapid response capability and over 40-year history of operating in Europe to provide the DoD with unique services in support of this complex and ongoing mission. Additionally, achieving full operational capability on LOGCAP V Kwajalein, approximately a month and a half ahead of schedule, has helped to expand our footprint in the INDOPACOM region. Activity in the region remains robust and our position continues to expand. For example, we recently expanded our scope of responsibilities at Subic Bay in the Philippines.  This program is expected to run over the next eight years and provides strategic logistics services to the DoD.  Work content in the INDOPACOM region now represents 9% of total revenue, up 3% from last year, and positions us well to support the DoD in a full range of operations over the next ten years.”

“Adjusted EBITDA for the quarter was strong at $24.7 million or 5.0% margin.  Adjusted EBITDA increased sequentially $6.5 million and was driven by higher revenue volume and success on operational excellence initiatives.  We remain focused on margin improvement, and this quarter’s results reflect our ability to expand earnings even as we execute on several programs in the early phases of period of performance. As we have noted in the past, LOGCAP V is generating higher revenue volume with a greater amount of material and pass-through content that has a different margin complexion. However, our teams are focused on driving program efficiencies and improving margin rates through contract add-on work while working with clients to convert certain components of work to more advantageous contract structures.”

Prow concluded, “Our second quarter results demonstrate the Company’s success in achieving top-line growth through increased work scope on existing programs, expansion of capabilities, broadening our geographic footprint, and adding new clients.  As we embark on the Company’s new chapter as V2X, I am excited about the greater scale, market leadership, and enhanced portfolio of offerings with the Vectrus/Vertex combination.”

Second quarter 2022 revenue of $498.1 million was up $27.2 million year on year.  “Revenue grew 6% year-over-year, driven by our transition to full operational capability on LOGCAP V programs in Iraq and Kuwait late last year, and INDOPACOM this year. In addition, revenue benefitted from transitioning Fort Benning and volume associated with rapid response and contingency efforts,” said Susan Lynch, Senior Vice President and Chief Financial Officer. “This revenue growth demonstrates achievement of our enterprise goal of growing the business through contract expansion and portfolio diversity despite the headwinds associated with the withdrawal of the US military from Afghanistan,” added Lynch. 

Operating income was $15.0 million or 3.0% margin.  This includes M&A and integration related expenses of $5.9 million and amortization of acquired intangible assets of $2.1 million which were incurred in the quarter.  Adjusted operating income1 was $23.0 million or 4.6% margin, increasing sequentially by $6.4 million and 100 basis points.  Adjusted EBITDA1 was $24.7 million or 5.0% margin, increasing sequentially by $6.5 million and 100 basis points.  Adjusted EBITDA margin compares to $26.6 million or 5.6% in the prior year period. “The year-on-year margin change was influenced by the significant amount of revenue and contracts that are in the early stages of their lifecycle.  In aggregate, on average and over time, we expect to see improvement in the margin profile as we drive operational efficiencies and diversify into higher margin scopes of work,” said Lynch.

Fully diluted EPS for the second quarter of 2022 was $0.88 as compared to $1.35 in the prior year.  Fully diluted EPS in the quarter included the aforementioned M&A and integration related costs.  Adjusted diluted EPS1 was $1.41 in the quarter as compared to $1.52 in the prior year. The year-on-year change in Adjusted diluted EPS1 was primarily due to the above-mentioned change in Adjusted EBITDA1.

Cash generated from operating activities for the quarter was $46.0 million.  Through July 1, 2022, net cash from operating activities was $19.6 million, compared to net cash from operating activities of $14.0 million through the second quarter of 2021. Cash from operating activities through the first half of 2022 was negatively impacted by an approximately $8.0 million repayment of CARES Act tax deferrals and $5.8 million of merger-related payments.

Net debt on July 1, 2022, was $58.4 million, compared to $105.2 million on July 2, 2021.  Total debt on July 1, 2022, was $90.2 million, down $84.8 million from $175.0 million on July 2, 2021. Cash at quarter-end was $35.1 million.  Total consolidated indebtedness to consolidated EBITDA1 (total leverage ratio) was 1.09x compared to 1.76x at the same time last year.

Total backlog as of July 1, 2022, was $4.6 billion.  Funded backlog was $1.3 billion. 

V2X
Guidance

Lynch continued, “We are establishing second half 2022 guidance ranges for V2X, which includes the contribution from both Vectrus and The Vertex Company.”

V2X guidance for the second half (2H) 2022 is as follows:

$
millions, except for EBITDA margins and per share amounts

V2X 2H 2022 Guidance

Revenue

$1,900

to

$1,940

Adjusted EBITDA1

$140

to

$150

Adjusted Diluted Earnings Per Share 1

$1.94

to

$2.19

Net Cash Provided by Operating Activities

$130

to

$150

Forward-looking statements are based upon current expectations and are subject to factors that could cause actual results to differ materially from those suggested here, including those factors set forth in the Safe Harbor Statement below. 

Second Quarter 2022 Conference Call

Management will conduct a conference call with analysts and investors at 4:30 p.m. ET on Tuesday, August 9, 2022. U.S.-based participants may dial in to the conference call at 877-242-2259, while international participants may dial 416-981-9017. A live webcast of the conference call as well as an accompanying slide presentation will be available on the Vectrus Investor Relations website at https://app.webinar.net/P4Qe37VDnop.

A replay of the conference call will be posted on the V2X website shortly after completion of the call and will be available for one year. A telephonic replay will also be available through August 23, 2022, at 844-512-2921 (domestic) or 412-317-6671 (international) with passcode 22020062.    

Footnotes:

1 See “Key Performance Indicators and Non-GAAP Financial Measures” for descriptions and reconciliations.

About V2X

V2X is a leading provider of critical mission solutions and support to defense clients globally, formed by the 2022 merger of Vectrus and The Vertex Company to build on more than 120 combined years of successful mission support. The Company delivers a comprehensive suite of integrated solutions across the operations and logistics, aerospace, training and technology markets to national security, defense, civilian and international clients. Our global team of approximately 14,000 employees brings innovation to every point in the mission lifecycle, from preparation, to operations, to sustainment, as it tackles the most complex challenges with agility, grit, and dedication.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 (the “Act”): Certain material presented herein includes forward-looking statements intended to qualify for the safe harbor from liability established by the Act. These forward-looking statements include, but are not limited to, all the statements and items listed in the table in “2022 Guidance” above and other assumptions contained therein for purposes of such guidance, other statements about our 2021 performance outlook, five-year growth plan, revenue, DSO, contract opportunities, the potential impact of COVID-19, and any discussion of future operating or financial performance.

Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “could,” “potential,” “continue” or similar terminology. These statements are based on the beliefs and assumptions of the management of the Company based on information currently available to management.

These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside our management’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements.  In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the Company’s historical experience and our present expectations or projections. For a discussion of some of the risks and important factors that could cause actual results to differ from such forward-looking statements, see the risks and other factors detailed from time to time our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the U.S. Securities and Exchange Commission.

We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

V2X, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

Three Months Ended

Six Months Ended

July 1,

July 2,

July 1,

July 2,

(In
thousands, except per share data)

2022

2021

2022

2021

Revenue

$      498,066

$             470,845

$         954,537

$         904,849

Cost of revenue

453,305

422,660

872,581

816,308

Selling, general, and administrative expenses

29,740

25,605

61,699

49,427

Operating income

15,021

22,580

20,257

39,114

Interest expense, net

(1,963)

(2,253)

(3,643)

(4,186)

Income from operations before income taxes

13,058

20,327

16,614

34,928

Income tax expense

2,586

4,393

3,287

6,946

Net income

$         10,472

$               15,934

$           13,327

$           27,982

Earnings per share

Basic

$           0.89

$                   1.36

$               1.13

$               2.40

Diluted

$           0.88

$                   1.35

$               1.12

$               2.37

Weighted average common shares
outstanding – basic

11,826

11,715

11,793

11,681

Weighted average common shares
outstanding – diluted

11,954

11,828

11,917

11,823

 

V2X, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

July 1,

December 31,

(In
thousands, except per share information)

2022

2021

Assets

Current assets

Cash and cash equivalents

$                   31,760

$                   38,513

Restricted cash

3,311

__—_

Receivables

374,980

348,605

Prepaid expenses

26,262

21,160

Other current assets

10,646

15,062

Total current assets

446,959

423,340

Property, plant, and equipment, net

23,530

23,758

Goodwill

321,734

321,734

Intangible assets, net

62,159

66,582

Right-of-use assets

39,705

43,651

Other non-current assets

11,760

10,394

Total non-current assets

458,888

466,119

Total Assets

$                 905,847

$                 889,459

Liabilities and Shareholders’ Equity

Current liabilities

Accounts payable

$                 244,080

$                 212,533

Compensation and other employee benefits

82,534

80,284

Short-term debt

10,400

10,400

Other accrued liabilities

48,322

55,031

Total current liabilities

385,336

358,248

Long-term debt, net

78,884

94,246

Deferred tax liability

32,489

32,214

Operating lease liability

30,719

34,536

Other non-current liabilities

14,941

20,128

Total non-current liabilities

157,033

181,124

Total liabilities

542,369

539,372

Commitments and contingencies (Note 9)

Shareholders’ Equity

Preferred stock; $0.01 par value; 10,000,000
shares authorized; No shares issued and outstanding

Common stock; $0.01 par value; 100,000 shares
authorized; 11,846 and 11,738 shares issued and
outstanding as of July 1, 2022, and December 31,
2021, respectively                                      

118

117

Additional paid in capital

91,464

88,116

Retained earnings

281,081

267,754

Accumulated other comprehensive loss

(9,185)

(5,900)

Total shareholders’ equity

363,478

350,087

Total Liabilities and Shareholders’ Equity

$                 905,847

$                 889,459

 

V2X, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

Six Months Ended

July 1,

July 2,

(In
thousands)

2022

2021

Operating activities

Net income

$              13,327

$              27,982

Adjustments to reconcile net income to net cash provided by
operating activities:

Depreciation expense

3,238

3,097

Amortization of intangible assets

4,423

4,891

(Gain) Loss on disposal of property, plant, and equipment

(15)

60

Stock-based compensation

4,725

4,923

Amortization of debt issuance costs

388

463

Changes in assets and liabilities:

Receivables

(29,302)

(38,882)

Prepaid expenses

(5,321)

(4,660)

Other assets

5,185

597

Accounts payable

32,470

18,784

Deferred taxes

370

Compensation and other employee benefits

2,507

11,285

Other liabilities

(11,989)

(14,884)

Net cash provided by operating activities

19,636

14,026

Investing activities

Purchases of capital assets

(3,492)

(4,833)

Proceeds from the disposition of assets

18

16

Business acquisition purchase price adjustment

262

Contribution to joint venture

(2,113)

(1,846)

Net cash used in investing activities

(5,587)

(6,401)

Financing activities

Repayments of long-term debt

(5,200)

(4,000)

Proceeds from revolver

392,000

215,000

Repayments of revolver

(402,000)

(215,000)

Proceeds from exercise of stock options

370

113

Payment of debt issuance costs

(458)

(17)

Payments of employee withholding taxes on share-based
compensation

(1,696)

(2,272)

Net cash used in financing activities

(16,984)

(6,176)

Exchange rate effect on cash

(507)

(373)

Net change in cash, cash equivalents and restricted cash

(3,442)

1,076

Cash, cash equivalents and restricted cash – beginning of year

38,513

68,727

Cash, cash equivalents and restricted cash – end of period

$              35,071

$              69,803

Supplemental disclosure of cash flow information:

Interest paid

$                3,409

$                3,111

Income taxes paid

$                6,112

$                5,747

Purchase of capital assets on account

$                    13

$                   618

Key Performance Indicators and Non-GAAP Measures

The primary financial performance measures we use to manage our business and monitor results of operations are revenue trends and operating income trends. Management believes that these financial performance measures are the primary drivers for our earnings and net cash from operating activities. Management evaluates its contracts and business performance by focusing on revenue, operating income, and operating margin. Operating income represents revenue less both cost of revenue and selling, general and administrative (SG&A) expenses. Cost of revenue consists of labor, subcontracting costs, materials, and an allocation of indirect costs, which includes service center transaction costs. SG&A expenses consist of indirect labor costs (including wages and salaries for executives and administrative personnel), bid and proposal expenses and other general and administrative expenses not allocated to cost of revenue. We define operating margin as operating income divided by revenue.

We manage the nature and amount of costs at the program level, which forms the basis for estimating our total costs and profitability. This is consistent with our approach for managing our business, which begins with management’s assessing the bidding opportunity for each contract and then managing contract profitability throughout the performance period.

In addition to the key performance measures discussed above, we consider adjusted operating income, adjusted operating margin, adjusted net income, adjusted diluted earnings per share, EBITDA, adjusted EBITDA, EBITDA margin, adjusted EBITDA margin, and organic revenue to be useful to management and investors in evaluating our operating performance, and to provide a tool for evaluating our ongoing operations. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives. We provide this information to our investors in our earnings releases, presentations, and other disclosures.

Adjusted operating income, adjusted operating margin, adjusted net income, adjusted diluted earnings per share, EBITDA, adjusted EBITDA, EBITDA margin, adjusted EBITDA margin, and organic revenue, however, are not measures of financial performance under GAAP and should not be considered a substitute for operating income, operating margin, net income, and diluted earnings per share as determined in accordance with GAAP.  Definitions and reconciliations of these items are provided below.

  • Adjusted
    operating income
     is defined as operating income, adjusted to exclude items that may include, but are not limited to significant charges or credits, and unusual and infrequent non-operating items, such as M&A, integration and related costs, LOGCAP V pre-operational legal costs, and amortization of acquired intangible assets that impact current results but are not related to our ongoing operations.
  • Adjusted
    operating margin
     is defined as adjusted operating income divided by revenue.
  • Adjusted
    net income
     is defined as net income, adjusted to exclude items that may include, but are not limited to, significant charges or credits, and unusual and infrequent non-operating items, such as M&A, integration and related costs, LOGCAP V pre-operational legal costs, and amortization of acquired intangible assets that impact current results but are not related to our ongoing operations.
  • Adjusted
    diluted earnings per share
     is defined as adjusted net income divided by the weighted average diluted common shares outstanding.
  • EBITDA is defined as operating income, adjusted to exclude depreciation and amortization.
  • Adjusted
    EBITDA
     is defined as EBITDA, adjusted to exclude items that may include, but are not limited to, significant charges or credits and unusual and infrequent non-operating items, such as M&A, integration and related costs, LOGCAP V pre-operational legal costs that impact current results but are not related to our ongoing operations.
  • EBITDA
    margin
     is defined as EBITDA divided by revenue.
  • Adjusted
    EBITDA margin
     is defined as Adjusted EBITDA divided by revenue.

 

Adjusted Net Income, Adjusted Diluted Earnings Per
Share (Non-GAAP Measures)

($K,
except per share data)

Three Months
Ended July
01, 2022 As
Reported

M&A,
Integration

and Related
Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible

Assets

Three
Months

Ended July
01, 2022 –
Adjusted

Revenue

$       498,066

$                      —

$                     —

$                     —

$       498,066

Growth

5.8 %

5.8 %

Operating income

$         15,021

$                5,879

$                     —

$          2,122

$         23,022

Operating margin

3.0 %

4.6 %

Interest expense, net

$          (1,963)

$                      —

$                     —

$                     —

$          (1,963)

Income from operations before income taxes

$            13,058

$                5,879

$                     —

$               2,122

$         21,059

Income tax expense

$               2,586

$                1,164

$                     —

$                  420

$           4,170

Income tax rate

19.8 %

19.8 %

Net income

$            10,472

$                4,715

$                     —

$               1,702

$         16,889

Weighted average common shares outstanding, diluted

11,954

11,954

Diluted earnings per share

$              0.88

$                  0.39

$                     —

$                 0.14

$             1.41

EBITDA (Non-GAAP Measures)

($K)

Three Months
Ended July
01, 2022 As
Reported

M&A,
Integration

and Related
Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible

Assets

Three
Months

Ended July
01, 2022 –
Adjusted

Operating Income

$         15,021

$                5,879

$                     —

$               2,122

$         23,022

Add:

Depreciation and amortization

$        3,769

$                      —

$                     —

$               (2,122)

$           1,647

EBITDA

$         18,790

$                5,879

$                     —

$                     —

$         24,669

EBITDA Margin

3.8 %

5.0 %

 

Adjusted Net Income, Adjusted Diluted Earnings Per
Share (Non-GAAP Measures)

($K,
except per share data)

Three Months
Ended July
02, 2021 As
Reported

M&A,
Integration

and Related
Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Three Months
Ended July
02, 2021 –
Adjusted

Revenue

$       470,845

$                     —

$                     —

$                     —

$       470,845

Operating income

$      22,580

$                     —

$                   21

$               2,436

$         25,037

Operating margin

4.8 %

5.3 %

Interest expense, net

$          (2,253)

$                     —

$                     —

$                     —

$          (2,253)

Income from operations before income taxes

$         20,327

$                     —

$                   21

$               2,436

$         22,784

Income tax expense

$            4,393

$                     —

$                     4

$                   463

$           4,860

Income tax rate

21.6 %

21.3 %

Net income

$         15,934

$                     —

$                   17

$               1,973

$         17,924

Weighted average common shares outstanding, diluted

11,828

11,828

Diluted earnings per share

$              1.35

$                     —

$                 0.00

$                 0.17

$              1.52

EBITDA (Non-GAAP Measures)

($K)

Three Months
Ended July
02, 2021 As
Reported

M&A,
Integration

and

Related Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Three Months
Ended July
02, 2021 –
Adjusted

Operating Income

$         22,580

$                     —

$                   21

$               2,436

$         25,037

Add:

Depreciation and amortization

$            3,991

$                     —

$                     —

$            (2,436)

$           1,555

EBITDA

$         26,571

$                     —

$                   21

$                     —

$         26,592

EBITDA Margin

5.6 %

5.6 %

 

Adjusted Net Income, Adjusted Diluted Earnings Per
Share (Non-GAAP Measures)

($K,
except per share data)

Six Months
Ended July
01, 2022 As
Reported

M&A,
Integration and
Related Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Six Months
Ended July
01, 2022 –
Adjusted

Revenue

$       954,537

$                     —

$                     —

$                     —

$      954,537

Growth

5.5 %

5.5 %

Operating income

$         20,257

$             14,947

$                   —

$               4,423

$        39,627

Operating margin

2.1 %

4.2 %

Interest expense, net

$          (3,643)

$                     —

$                     —

$                     —

$         (3,643)

Income from operations before income taxes

$         16,614

$             14,947

$                   —

$               4,423

$        35,984

Income tax expense

$            3,287

$               2,957

$                     —

$                    875

$          7,119

Income tax rate

19.8 %

19.8 %

Net income

$              13,327

$             11,990

$                   —

$               3,548

$        28,865

Weighted average common shares outstanding, diluted

11,917

11,917

Diluted earnings per share

$              1.12

$                 1.01

$                 —

$                 0.30

$             2.42

EBITDA (Non-GAAP Measures)

($K)

Six Months
Ended July
01, 2022 As
Reported

M&A,
Integration and
Related Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Six Months
Ended July
01, 2022 –
Adjusted

Operating Income

$         20,257

$             14,947

$                   —

$               4,423

$        39,627

Add:

Depreciation and amortization

$            7,661

$                     —

$                     —

$                (4,423)

$            3,238

EBITDA

$         27,918

$             14,947

$                   —

$                     —

$        42,865

EBITDA Margin

2.9 %

4.5 %

 

Adjusted Net Income, Adjusted Diluted Earnings Per
Share (Non-GAAP Measures)

($K,
except per share data)

Six Months
Ended July
02, 2021 As
Reported

M&A,
Integration and
Related Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Six Months
Ended July
02, 2021 –
Adjusted

Revenue

$      904,849

$                    —

$                    —

$                    —

$      904,849

Operating income

$        39,114

$                     —

$                 178

$              4,891

$        44,183

Operating margin

4.3 %

4.9 %

Interest expense, net

$         (4,186)

$                    —

$                    —

$                    —

$         (4,186)

Income from operations before income taxes

$        34,928

$                     —

$                 178

$              4,891

$        39,997

Income tax expense

$          6,946

$                     —

$                   34

$                 929

$          7,909

Income tax rate

19.9 %

19.9 %

Net income

$        27,982

$                     —

$                 144

$              3,962

$        32,088

Weighted average common shares outstanding, diluted

11,823

11,823

Diluted earnings per share

$             2.37

$                     —

$                0.01

$                0.33

$             2.71

EBITDA (Non-GAAP Measures)

($K)

Six Months
Ended July
02, 2021 As
Reported

M&A,
Integration and
Related Costs

LOGCAP V
Pre-

Operational

Legal Costs

Amortization
of Acquired
Intangible Assets

Six Months
Ended July
02, 2021 –
Adjusted

Operating Income

$        39,114

$                     —

$                 178

$              4,891

$        44,183

Add:

Depreciation and amortization

$          7,988

$                    —

$                    —

$           (4,891)

$          3,097

EBITDA

$        47,102

$                     —

$                 178

$                    —

$        47,280

EBITDA Margin

5.2 %

5.2 %

 

 

SUPPLEMENTAL INFORMATION

Revenue by client branch, contract type, contract relationship, and geographic region for the periods presented below was as follows: 

Revenue
by Client

Three Months Ended

Six Months Ended

July 1,

July 2,

July 1,

July 2,

(In
thousands)

2022

%

2021

%

2022

%

2021

%

Army

$    326,756

65 %

$    310,638

66 %

$     606,869

63 %

$      567,987

63 %

Air Force

68,457

14 %

63,206

13 %

129,930

14 %

141,375

16 %

Navy

64,885

13 %

56,399

12 %

140,102

15 %

112,827

12 %

Other

37,968

8 %

40,602

9 %

77,636

8 %

82,660

9 %

Total revenue

$    498,066

$    470,845

$     954,537

$      904,849

Revenue
by Contract Type

Three Months Ended

Six Months Ended

July 1,

July 2,

July 1,

July 2,

(In
thousands)

2022

%

2021

%

2022

%

2021

%

Cost-plus and cost-reimbursable

$    355,559

71 %

$    344,189

73 %

$     666,653

70 %

$      634,420

70 %

Firm-fixed-price

128,348

26 %

111,416

24 %

256,352

27 %

240,173

27 %

Time and material

14,159

3 %

15,240

3 %

31,532

3 %

30,256

3 %

Total revenue

$    498,066

$    470,845

$     954,537

$      904,849

Revenue
by Contract Relationship

Three Months Ended

Six Months Ended

July 1,

July 2,

July 1,

July 2,

(In
thousands)

2022

%

2021

%

2022

%

2021

%

Prime contractor

$    468,453

94 %

$    440,040

93 %

$     895,546

94 %

$      843,303

93 %

Subcontractor

29,613

6 %

30,805

7 %

58,991

6 %

61,546

7 %

Total revenue

$    498,066

$    470,845

$     954,537

$      904,849

Revenue
by Geographic Region

Three Months Ended

Six Months Ended

July 1,

July 2,

July 1,

July 2,

(In
thousands)

2022

%

2021

%

2022

%

2021

%

Middle East

$    250,222

50 %

$    258,488

55 %

$     485,313

51 %

$      498,500

55 %

United States

158,719

32 %

146,549

31 %

325,454

34 %

296,362

33 %

Europe

42,739

9 %

36,084

8 %

81,178

8 %

76,706

8 %

Asia

46,386

9 %

29,724

6 %

62,592

7 %

33,281

4 %

Total revenue

$    498,066

$    470,845

$     954,537

$      904,849

CONTACT: 
V2X, Inc. 
Mike Smith, CFA
719-637-5773

 


Should Medical Cannabis Patients be Forbidden from Owning Firearms?



Image Credit: Raymond Clark (Flickr)


The DOJ’s Case Against Allowing Medical Marijuana Users from Purchasing a Gun

Is it  “dangerous to trust regular marijuana users to exercise sound judgment” with firearms? The Department of Justice responded to a lawsuit asking the court to dismiss a medical marijuana lawsuit on Monday (August 7). The suit was filed by an agriculture official in Florida. The circumstances involved patients using cannabis; it claims that the federal government is unconstitutionally depriving them of their Second Amendment right to purchase and possess firearms. The DOJ asked a federal court to dismiss the lawsuit claiming it seeks to overturn policy involving medical marijuana users and their inability to own firearms.

The suit was filed by Agriculture and Consumer Services Commissioner Nikki Fried (D), who is a candidate in Florida for governor. It made a unique legal argument that a congressional spending rider prevents the use of Justice Department funds to interfere in the implementation of medical marijuana programs.

Presently, in order to buy a gun, citizens are required to fill out a federal form that explicitly asks about the use of (federally) illegal drugs. Applicants that use cannabis, which is legal for medical use in Florida, are not allowed to purchase a gun and could face up to five years in prison if they lie on the application.

This case has national implications and is of interest not just to those that benefit from medical cannabis but also to investors in medical marijuana.


Components of the Case

The suit alleges a federal rule that bars medical marijuana patients from having guns is unconstitutional.

In its motion to dismiss the case or secure a favorable judgment, the U.S. DOJ claimed that the policies being challenged by the lawsuit only apply to people who use illegal drugs, in this case, cannabis. Therefore, Second Amendment rights of law-abiding citizens are not barred.

“These laws merely prevent drug users who commit federal crimes by unlawfully possessing drugs from possessing and receiving firearms, and only for so long as they are actively engaged in that criminal activity,” the DOJ brief to dismiss claimed.

The DOJ referenced Florida’s own medical consent form accepted by Florida marijuana regulators; the DOJ noted that it warns, that marijuana “impairs judgment, cognition and physical coordination, including ‘the ability to think, judge and reason.'” The DOJ added that there was a deeply rooted practice in American law and policy of not allowing dangerous or lawbreaking individuals to possess firearms.

“A long tradition exists of viewing intoxication as a condition that renders firearms possession dangerous, and accordingly restricting the firearms rights of those who become intoxicated,” the brief said.

In the complaint, filed April 20, 2022, the plaintiffs claim the central question in the case is whether the physical and/or psychological effects of medical marijuana render users “sufficiently dangerous or violent” so that possession or use of a firearm would cause concern.

They further referenced a study that demonstrated that medical marijuana has no such effect. The plaintiffs referenced the 2013, Office of National Drug Control Policy study that concluded there was “little support for a contemporaneous, causal relationship between the use of marijuana ‘and either violent or property crime.'”

In its Monday brief, the DOJ countered that “marijuana users with firearms pose a danger comparable to, if not greater than, other groups that have historically been disarmed,” in part because cannabis remains federally illegal.

The government argued further that Nicole Fried, the state Department of Agriculture and Consumer Services commissioner who brought the lawsuit, had no standing to bring the action since she did not allege her right to possess firearms had been infringed.

The DOJ is seeking the dismissal of all claims.

The case is Fried et al. v. Garland et al., case number 4:22-cv-00164, in the U.S. District Court for the Northern District of Florida.


Take Away

It is presumed by many that marijuana for medical use and study will at some point be
dropped as a schedule 1 drug. Despite a number of bills in the house and the Senate that, if passed and signed into law, would accomplish reclassification, to date, marijuana is still illegal on a federal level.

The status is complicated by the fact that 37 of the 50 states allow medical use for qualified individuals. The case filed by Florida’s Agricultural Secretary Fried attempts to still uphold second amendment rights to those approved for and using medical marijuana in Florida. The U.S. Department of Justice is opposed.

There is no indication whether a change in federal legal status would change, in the DOJ’s mind, the dangers of allowing firearm ownership to these patients.

Paul Hoffman

Managing Editor, Channelchek

Suggested Content



Senate Marijuana Bill Expected Before Summer Break



Lawmakers and Insider Trading Laws




Cannabis Vape Distribution Limited Under New Law



Evaluating Opportunity With the iPhone New Marijuana Policy


Sources

https://www.orlandosentinel.com/news/os-ne-prem-nikki-fried-medical-marijuana-20210611-dzil5daz7rfw7k7mjf6szxpo7y-story.html

https://www.marijuanamoment.net/florida-official-sues-biden-administration-over-gun-rights-for-medical-marijuana-patients-on-4-20/

https://www.law360.com/health/articles/1519290/doj-says-medical-pot-patients-have-no-right-to-bear-arms?copied=1

https://unicourt.com/case/pc-db5-fried-et-al-v-garland-et-al-1182072

https://www.dea.gov/sites/default/files/2020-06/Marijuana-Cannabis-2020_0.pdf

Stay up to date. Follow us:

 

Cathie Wood’s Expectations for Inflation, Recession, Markets, China, and Jobs



Image: Bloomberg TV (August 8, 2022)


Why Cathie Wood Thinks We Will Emerge from A Recession More Quickly than Others

Cathie Wood, the founder, and CIO of Ark Invest, was asked in an interview, “Is the Fed going to continue hiking rates, or are they going to stop and turn around and come back down next year?” Her response was not initially uplifting, but as she explained why her firm has evaluated the current economic growth trajectory and what the future may bring, the fund manager, that focuses on innovative sectors, was actually optimistic.


Are Jobs Strong?

Wood brought up July’s huge unexpected increase in Non-Farm Payroll and contrasted it with the Household Employment numbers (a broader-based survey). She reminded the Bloomberg interviewer that Household Employment “…has been flat to down for the last four months.”  She added, “If you look at [unemployment] claims, we’ve never seen a faster increase.” She thinks people don’t weigh in the fact that we are up 50% off the low in unemployment. Cathie Wood also mentioned that large numbers of people are being laid off, then she referenced a Challenger survey that reported layoffs are up 55-60% year-over-year.

The reason she gave for the layoffs is inventory levels. “We have a massive inventory glut.” She believes the push to hire is ending and unwinding.


Is Inflation a Non-Issue?

Cathie Wood had been on record as previously saying, “deflation is more of a concern than inflation.” She was asked if she still feels this way. “I still think that because the evidence is piling up. Now the CPI and to some measure the PPI, both of those are lagging indicators.” She emphasized, “The Fed is driving policy off lagging indicators.”

What she prefers to look at is the price of commodities used for building and growth like copper. She said that copper took a decisive break to the downside (20%), but the decrease hasn’t yet fed into the inflation indexes. Wood says a better measure of where inflation is headed is gold. “Prices [Gold] peaked August 2020, we’ve been in a trading range, we’re at the low end of the trading range now.” She believes if the Fed continues to tighten, her firm’s expectation is the dollar will turn back up, and commodities will continue
to fall
.

The next inflation report is due Wednesday (August 10). An Econoday consensus estimate puts July headline inflation at 8.7%, cooling from 9.1% in June.


Are We in a Recession?

“Yes, we believe we are in a recession.” Wood told the interviewer. She explained that the economy receded for two consecutive quarters, which is the beginning of the definition. Three consecutive declines in leading indicators would suggest the same, she explained. “Our point of view is this is going to be a severe inventory recession, but we don’t have the systemic excesses like we did pre-2008, 2009 in the mortgage market.” She explained that while many economists use the inverted yield curve and say it indicates a recession next year, she believes we will be coming out of our current recession next year.


What’s Going on in China?

Cathie Wood says the big question is what is going on in China? She offered that perhaps the commodity prices unraveling has to do with the Chinese economy, especially their growth-inhibiting policies and real estate problems. She thinks China’s economy is going to be more difficult for them to control than they anticipated.


Why Stay Invested?

She was asked if it makes sense to move to cash since there are possible trouble spots on the horizon. In classic, confident optimism, Cathie Wood responded, “We are going to stay 100% in innovation.” Her reason is innovation is going to be a critical allocation in the years ahead. She explained, “Innovation saves time. Innovation solves problems.” She then listed the current problems, as supply chain, and energy, and food price increases. “Better, cheaper, faster, more productive, more efficient, more creative, is going to win,”  she exclaimed.

Wood thinks most asset allocators are short the innovation categories. Her idea of the sector is not current day high tech Nasdaq 100, but what Nasdaq used to be in the 1990s.

The Federal Reserve will reverse course on interest-rate policy next year by yanking down borrowing rates in the face of weaker activity in the US economy, disruptive-tech investor Cathie Wood told Bloomberg TV.

“We’re getting all kinds of signals that the economy is very weak,” which will prompt the Fed to start rate cuts in 2023, she said Monday.

 

Take Away

The well-followed manager always has strong convictions, they are often contrary to popular opinion. These forecasts have both served her firm and investors well and have caused disappointment when the volatile innovative sector is giving back gains.

She said that she will stay 100% invested as the industries and companies her funds are most heavily weighted in will be the kind of companies that help resolve issues weighing on consumers and economies today.

Did you know Channelchek has no paywall – and never will? Take the time to sign-up now for regular emails on quality research of innovative companies and insightful articles and ideas.

Paul Hoffman

Managing Editor, Channelchek

Suggested Content



Cathie Wood Thinks if There is No Blood in Your Street, You Should Move



Michael Burry vs Cathie Wood is Not an Even Competition




Peter Lynch Echoes Michael Burry’s Warning About Index Investments



A Look at Global Inflation and its Causes


https://www.bloomberg.com/news/videos/2022-08-08/cathie-wood-on-the-fed-economy-coinbase-tesla-video

https://www.econoday.com/august-boe-mpc-preview-time-for-a-change-of-gear/

Stay up to date. Follow us:

 

Aurania Resources (AUIAF) – Sowing the Seeds for a Successful Drilling Program

Tuesday, August 09, 2022

Aurania Resources (AUIAF)
Sowing the Seeds for a Successful Drilling Program

Mark Reichman, Senior Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Geological mapping update. As a follow up to our note published on July 27, geological mapping at the company’s porphyry copper-gold target Tatasham is expected to be completed in the next few weeks. The second phase of mapping at the company’s porphyry copper-gold Awacha target is planned to start by the end of August.

Excitement builds around Tatasham and Awacha. The geological mapping program, under the guidance of Dr. Steve Garwin, Senior Technical Advisor, employs the Anaconda mapping method to define drill targets at Tatasham and Awacha. The Anaconda method owes its name to Anaconda Copper where it was developed in the 1960s and 1970s and was instrumental in the discovery and resource expansion of several porphyry copper-gold deposits, including the Alpala deposit in the the Cascabel concession in Ecuador, and the Cortadera deposit in Chile. In our view, the comprehensive mapping program should support a productive drilling program and enhance the probability of successful outcomes….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

ACCO Brands (ACCO) – First Look: 2Q22

Tuesday, August 09, 2022

ACCO Brands (ACCO)
First Look: 2Q22

ACCO Brands Corporation is one of the world’s largest designers, marketers and manufacturers of branded academic, consumer and business products. Our widely recognized brands include AT-A-GLANCE®, Esselte®, Five Star®, GBC®, Kensington®, Leitz®, Mead®, PowerA®, Quartet®, Rapid®, Rexel®, Swingline®, Tilibra®, and many others. Our products are sold in more than 100 countries around the world. More information about ACCO Brands, the Home of Great Brands Built by Great People, can be found at www.accobrands.com.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

2Q22 Operating Results. ACCO reported 2Q22 revenue of $521 million, up 0.6% year-over-year and up 5.2% on a comparable basis, with all segments posting growth. ACCO has now recorded five consecutive quarters of comparable sales growth. We had forecast revenue of $545 million. Adjusted EPS was $0.37, compared to $0.43 last year. We had forecast adjusted EPS of $0.44.

Forex, Economic Conditions Restrain Growth. Slower economic growth, increased inflation, and unfavorable foreign currency impacts resulted in a more challenging quarter than anticipated. Adverse foreign exchange reduced sales by $23.6 million in the quarter, while a lack of computer chips resulted in lower sales of gaming accessories. Operating income benefited from $9.4 million of contingent earnout income related to the PowerA acquisition….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Pyxis Tankers (PXS) – Outstanding quarter shows sensitivity to shipping rates

Tuesday, August 09, 2022

Pyxis Tankers (PXS)
Outstanding quarter shows sensitivity to shipping rates

We currently own a modern fleet of five tankers engaged in seaborne transportation of refined petroleum products and other bulk liquids. We are focused on growing our fleet of medium range product tankers, which provide operational flexibility and enhanced earnings potential due to their “eco” features and modifications. We are positioned to opportunistically expand and maximize our fleet due to competitive cost structure, strong customer relationships and an experienced management team whose interests are aligned with those of its shareholders. For more information, visit: http://www.pyxistankers.com.

Michael Heim, CFA, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Pyxis reported strong top-line results due to higher shipping rates. Results carried through to earnings. Pyxis reported 2022-2Q net revenues of $16.1 million vs. $7.7 million for the same period last year as higher energy prices and a disruption in global oil flow routes due to the Russia/Ukraine war resulted in higher tanker shipping rates. The average TCE rate for the quarter was $21,070 vs. $12,280 and could go higher in the third quarter with 57% of capacity fixed at $30,500. Meanwhile, operating costs per day declined to $6,181 from $6,697 leading to net income of $4.6 million or $0.38 per diluted versus ($1.4 million) or ($0.16 per share).

Cash flow is strong and the balance sheet is reasonable. Adjusted EBITDA was $7.3 million up from $0.4 million. The company’s cash position has grown to $6.2 million with $73.8 million in debt. Debt represents approximately 60% of capitalization (net debt is 55%). Debt is well supported by a increasingly more valuable asset base. Financing costs are an average 4.6%. The utilization rate for the quarter was 98%, a large improvement above first quarter rates of 74% that suffered from the accidental grounding of a tanker….

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Information Services Group (III) – Another Solid Quarter

Tuesday, August 09, 2022

Information Services Group (III)
Another Solid Quarter

ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 700 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For additional information, visit www.ISG-One.com

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

More Records. ISG announced revenue of $70.7 million for the second quarter, flat with the $70.6 million in the year ago period. On a constant currency basis, revenue rose 5%. The quarter had record net income of $5.0 million, or $0.10 fully diluted EPS, versus $4.1 million and $0.08 the previous year. Adjusted EBITDA also was a record at $10.7 million, a 10% increase year-over-year.

Quarterly Drivers. Revenue was negatively impacted by a higher forex headwind than anticipated. In addition, the completion of a large Automation contract and relatively soft environment in the vertical negatively impacted overall revenue. Nonetheless, ISG continues to see growing demand for specialized services like cybersecurity, data analytics, application development, and technology modernization as well as an increased focus from clients on cost optimization….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Release – Tonix Pharmaceuticals to Present at the 2022 Virtual Q3 Investor Summit



Tonix Pharmaceuticals to Present at the 2022 Virtual Q3 Investor Summit

Research, News, and Market Data on Tonix Pharmaceuticals

August 09, 2022 7:00am EDT

CHATHAM, N.J., Aug. 09, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, will present at the Virtual Q3 Investor Summit on Tuesday, August 16, 2022, at 9:30 a.m. ET.

Investors interested in arranging a meeting with the Company’s management during the conference should contact the Investor Summit conference coordinator. A webcast of the presentation can be found 
here and will be available under the IR Events tab of the Tonix website at www.tonixpharma.com.

About Tonix Pharmaceuticals
Holding Corp.
*

Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is composed of central nervous system (CNS), rare disease, immunology and infectious disease product candidates. Tonix’s CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix’s lead CNS candidate, TNX-102 SL (cyclobenzaprine HCl sublingual tablet), is in mid-Phase 3 development for the management of fibromyalgia with a new Phase 3 study launched in the second quarter of 2022 and interim data expected in the first quarter of 2023. TNX-102 SL is also being developed to treat Long COVID, a chronic post-acute COVID-19 condition. Tonix expects to initiate a Phase 2 study in Long COVID in the third quarter of 2022. TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication that is Phase 2 ready and has been granted Breakthrough Therapy designation by the FDA. TNX-1900 (intranasal potentiated oxytocin), a small molecule in development for chronic migraine, is expected to enter the clinic with a Phase 2 study in the first half of 2023. Tonix’s rare disease portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome. TNX-2900 has been granted Orphan Drug designation by the FDA. Tonix’s immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. A Phase 1 study of TNX-1500 is expected to be initiated in the first half of 2023. Tonix’s infectious disease pipeline consists of a vaccine in development to prevent smallpox and monkeypox, next-generation vaccines to prevent COVID-19, and a platform to make fully human monoclonal antibodies to treat COVID-19. TNX-801, Tonix’s vaccine in development to prevent smallpox and monkeypox, also serves as the live virus vaccine platform or recombinant pox vaccine (RPV) platform for other infectious diseases. A Phase 1 study of TNX-801 is expected to be initiated in Kenya in the first half of 2023. Tonix’s lead vaccine candidate for COVID-19 is TNX-1850, a live virus vaccines based on Tonix’s recombinant pox live virus vector vaccine platform. A Phase 1 study of the COVID-19 vaccine is expected to be initiated in the second half of 2023.

*All of Tonix’s product candidates are investigational new drugs or biologics and have not been approved for any indication.

This press release and further information about Tonix can be found at www.tonixpharma.com.

Forward
Looking Statements

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate,” “expect,” and “intend,” among others. These forward-looking statements are based on Tonix’s current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, risks related to the failure to obtain FDA clearances or approvals and noncompliance with FDA regulations; delays and uncertainties caused by the global COVID-19 pandemic; risks related to the timing and progress of clinical development of our product candidates; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or third party payor reimbursement; limited research and development efforts and dependence upon third parties; and substantial competition. As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. Tonix does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in the Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the Securities and Exchange Commission (the “SEC”) on March 14, 2022, and periodic reports filed with the SEC on or after the date thereof. All of Tonix’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date thereof.

Contacts

Jessica Morris (corporate)
Tonix Pharmaceuticals
investor.relations@tonixpharma.com
(862) 799-8599

Olipriya Das, Ph.D. (media)
Russo Partners
Olipriya.Das@russopartnersllc.com
(646) 942-5588

Peter Vozzo (investors)
ICR Westwicke
peter.vozzo@westwicke.com
(443) 213-0505


Primary Logo

Source: Tonix Pharmaceuticals Holding Corp.

Released
August 9, 2022


Release – Comstock Announces Second Quarter 2022 Results



Comstock Announces Second Quarter 2022 Results

Research, News, and Market Data on Comstock Mining

Cellulosic
Breakthrough Unlocks Massive New Feedstock Model for Net Zero Energy
Independence

VIRGINIA
CITY, NEVADA, AUGUST 9, 2022
 – Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced its recent business development highlights, second quarter 2022 results, and updated outlook.  

Selected Strategic Highlights – Cellulosic Fuels

  • Expanded our leading cellulosic fuels technology portfolio by filing for a new patent covering breakthrough pathways to produce Bioleum a renewable offset for petroleum and multiple drop-in renewable fuels from woody biomass.
  • Filed a preliminary application for a U.S. Department of Energy (“DOE”) grant opportunity for a pilot scale system to validate enhanced production metrics of purified bio-intermediaries and renewable fuels from woody biomass.
  • Received a notification of “encouragement” from the U.S. Department of Energy for this same grant opportunity.
  • Established strategic collaborations with leading industry partners, including feedstock and offtake relationships, for the development of renewable fuels, from woody biomass, at dramatically improved yield, efficiency, and cost.
  • Advanced the engineering and development of our cellulosic fuel demonstration facility.

Selected Strategic Highlights – Lithium Extraction
and Electrification Products

  • Commissioned our proprietarylithium-ion battery (“LIB”) pilot crushing, separation, and conditioning system.
  • Enhanced the design and commenced upgrades on our proprietary LIB pilot crushing and separation system.
  • Completed construction of our prototype lithium extraction system in our R&D facility and commenced testing.
  • Advanced permitting for our state-of-the-art battery metal recycling facility in Nevada.
  • Production of high-purity black mass to commence in our battery metal recycling facility by Q2 2023.
  • Production of battery grade lithium carbonate to commence in our battery metal recycling facility by Q3 2023.

Selected Financial Highlights

  • Total assets were $117,826,063 as of June 30, 2022, as compared to $115,119,393 at March 31, 2022.
  • Operating expenses were $5,896,617 for the second quarter 2022, including selling, general and administrative expenses of $2,508,573 and research and development expenses of $2,579,150, and depreciation of $808,894.
  • Second quarter 2022 net loss was $13,766,846 or $(0.20) per share, as compared to second quarter 2021 net loss of $6,320,992 or $(0.15) per share. The 2022 results were primarily driven by increases in research and development expenditures and changes in fair values of derivatives.
  • Advanced non-strategic asset monetization efforts with asset sales proceeds expected at $20 million. 
  • Debt was $4,572,356 on June 30, 2022, net of discount, representing an unsecured promissory note.
  • Cash and cash equivalents were $4,345,315 on June 30, 2022.
  • Outstanding common shares were 76,822,049 at June 30, 2022, and 78,737,632 at August 8, 2022.

“Our financial results reflect the impact of our continued investment in the research, development and commercialization of our renewable energy businesses,” said Corrado De Gasperis, Comstock’s executive chairman and chief executive officer. “The building and operating of these proprietary demonstration systems are critical prerequisites for full scale commercialization.”

Cellulosic Fuels

The Company recently announced a significant expansion of its leading cellulosic technology portfolio by filing for a new patent covering breakthrough pathways to produce renewable diesel, sustainable aviation fuel (“SAF”) gasoline and marine fuel from woody biomass, at dramatically improved yield, efficiency, and cost in comparison to all known methods.

Renewable fuels provide a critical opportunity for decarbonization, however, most of the existing U.S. renewable fuel refineries draw from the same limited pool of constrained feedstocks. Comstock’s plans to decarbonize with renewable fuels involves abundant feedstocks that are not used today, enabling a vast untapped energy source with superior benefits. 

“Our new patent covers processes and compositions that have been validated at our existing two ton per day cellulosic fuels pilot facility, verifying that we can simultaneously produce multiple purified biointermediates that are uniquely isolated and free of the contaminants that have frustrated prior attempts at commercializing cellulosic fuel technologies,” added De Gasperis.

Based on current data, Comstock projects best-in-class renewable yields exceeding 80 gallons per dry ton of woody biomass (on a gasoline gallon equivalent basis), with lifecycle greenhouse gas emissions reductions exceeding 80% over petroleum.

The Company is currently expanding its existing cellulosic demonstration systems to include the production of Bioleum™ and expects these demonstration systems to add to our existing capabilities for producing carbon-neutral pulps, cellulosic sugar and cellulosic ethanol.  The expansion into Bioleum™ will demonstrate the full capability of producing these bio-intermediaries suitable for the production of renewable diesel, marine, SAF and gasoline from woody biomass.

The Company recently submitted a preliminary grant application to the U.S. Department of Energy (“DOE”) entitled “Production of Renewable Diesel,
Sustainable Aviation Fuel, Gasoline, and Marine Fuel from Lignocellulosic
Biomass at Dramatically Improved Yield, Efficiency, and Cost” 
and received a DOE notification of encouragement to apply for this funding opportunity, reflecting positively on the Company technology readiness and the strength of its collaboration partners.

De Gasperis continued, “The existing U.S. biorefining capacity is far greater than current feedstocks can support, and the DOE clearly recognizes the need for expanded feedstocks. We believe that our expanded technology solutions, and the magnitude of feedstocks that they enable, unblock one of the most critical supply chain constraints across the U.S. and global markets.”

Electrification Products

The Company completed construction and initial commissioning of its breakthrough LIB crushing, separating, and conditioning process during the second quarter, successfully confirming the production of highly concentrated “black mass.”

“We have successfully developed a proprietary system that produces a novel and pure black mass, further positioning us for high efficiency metals extraction, starting with lithium,” said Mr. De Gasperis. “Our team is enhancing the pilot system for deployment in Nevada where we will ultimately integrate our black mass production and lithium extraction process in 2023.”  

The Company expects to receive its main operating permit during the fourth quarter of 2022 and complete the submission of its modified air quality permits for our LIB processes at our state-of-the-art, battery metal recycling facility in the third quarter.

“The cleaning and repairs of our facility in Nevada are near complete and truly look outstanding.  The facility can now be readied for the receipt and installations of pilot and demonstration units for crushing, separating and conditioning of our novel black mass and subsequently, our lithium extraction, while the permitting process continues” concluded Mr. De Gasperis.

Corporate

Cash and cash equivalents were $4,345,315 on June 30, 2022. The Company expects over $20 million in proceeds over the next two quarters from the sale of its non-mining properties, non-strategic investments, and collection of advances receivable, including the Daney Ranch for $2.5 million, net, and proceeds from Sierra Springs Opportunity Fund totaling over $18 million.

Conference Call Details

Comstock will host the conference call on Tuesday, August 9, 2022, at 1:15 p.m. PDT  (4:15 p.m. EDT) and the webcast will include a moderated question and answer session following the Company’s prepared remarks.  Please click the link below to register in advance and please join the event at least 10 minutes prior to the scheduled start time. Once registered, you will receive a confirmation email containing information about joining the Webcast. Please 
click here to register in advance.

About
Comstock

Comstock (NYSE: LODE) innovates technologies that contribute to global decarbonization and circularity by efficiently converting under-utilized natural resources into renewable fuels and electrification products that contribute to balancing global uses and emissions of carbon. The Company intends to achieve exponential growth and extraordinary financial, natural, and social gains by building, owning, and operating a fleet of advanced carbon neutral extraction and refining facilities, by selling an array of complimentary process solutions and related services, and by licensing selected technologies to qualified strategic partners. To learn more, please visit www.comstock.inc.

Forward-Looking
Statements 

This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements, but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: future industry market conditions; future explorations or acquisitions; future changes in our exploration activities; future changes in our research and development; and future prices and sales of, and demand for, our products and services. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Neither this press release nor any related call or discussion constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company, the fund or any other issuer.

  Contact
information:

 

 

Comstock Mining Inc.
P.O. Box 1118
Virginia City, NV 89440
www.comstock.inc

Corrado De Gasperis
Executive Chairman & CEO
Tel (775) 847-4755
degasperis@comstockmining.com

Zach Spencer
Director of External Relations
Tel (775) 847-5272 Ext.151
questions@comstockmining.com

 


Release – Harte Hanks to Present at the 12th Annual Midwest IDEAS Investor Conference on August 24th and 25th in Chicago, IL



Harte Hanks to Present at the 12th Annual Midwest IDEAS Investor Conference on August 24th and 25th in Chicago, IL

Research, News, and Market Data on Harte Hanks

CHELMSFORD, MA / ACCESSWIRE / August 9, 2022 / Harte Hanks, Inc. (NASDAQ:HHS), a leading global customer experience company focused on bringing companies closer to customers for nearly 100 years, today announced that Brian Linscott,its Chief Executive Officer, will present at the Midwest IDEAS Investor Conference on Wednesday, August 24, 2022, at The Gwen in Chicago, IL. Harte Hanks’s presentation is scheduled to begin at 11:00am CT. The presentation will be webcast and may be accessed through the conference host’s main website: https://www.threepartadvisors.com/midwest and in the investor relations section of the company’s website: https://investors.hartehanks.com/.

About IDEAS Investor Conferences

The mission of the IDEAS Conferences is to provide independent regional venues for quality companies to present their investment merits to an influential audience of investment professionals. Unlike traditional bank-sponsored events, IDEAS Investor Conferences are “SPONSORED BY INVESTORS. FOR
INVESTORS.”
 and for the benefit of regional investment communities. Conference sponsors collectively have more than $200 billion in assets under management and include: 1102 Partners, Adirondack Research and Management, Allianz Global Investors: NFJ Investment Group, Ariel Investments, Aristotle Capital Boston, Barrow Hanley Mewhinney & Strauss, BMO Global Asset Management, Constitution Research & Management, Inc., Fidelity Investments, First Wilshire Securities Management, Inc., Gamco Investors, Granahan Investment Management, Great Lakes Advisors, Greenbrier Partners Capital Management, LLC, GRT Capital Partners, LLC, Hodges Capital Management, Ironwood Investment Management, Keeley Teton Advisors, Luther King Capital Management, Marble Harbor Investment Counsel, North Star Investment Management, Perritt Capital Management, Punch & Associates, Westwood Holdings Group, Inc., and William Harris Investors.

The IDEAS Investor Conferences are held annually in Boston, Chicago and Dallas and are produced by Three Part Advisors, LLC. Additional information about the events can be located at www.IDEASconferences.com.

If interested in participating or learning more about the IDEAS conferences, please contact Lacey Wesley at (817) 769 -2373 or lwesley@threepa.com.

About Harte Hanks:

Harte Hanks (Nasdaq:HHS) is a leading global customer experience company whose mission is to partner with clients to provide them with CX strategy, data-driven analytics and actionable insights combined with seamless program execution to better understand, attract and engage their customers. Using its unparalleled resources and award-winning talent in the areas of Customer Care, Fulfillment and Logistics, and Marketing Services, Harte Hanks has a proven track record of driving results for some of the world’s premier brands, including Bank of America, GlaxoSmithKline, Unilever, Pfizer, HBOMax, Volvo, Ford, FedEx, Midea, Sony and IBM among others. Headquartered in Chelmsford, Massachusetts, Harte Hanks has over 2,500 employees in offices across the Americas, Europe, and Asia Pacific.

Investor Relations Contact:

FNK IR
Rob Fink or Tom Baumann
646.809.4048 / 646.349.6641
HHS@fnkir.com

For media inquiries, contact Jennifer London at Jen.London@HarteHanks.com

SOURCE: Harte Hanks, Inc.

 

Great Lakes Dredge & Dock (GLDD) – Corrected Copy: Income Statement Model

Monday, August 08, 2022

Great Lakes Dredge & Dock (GLDD)
Corrected Copy: Income Statement Model

Great Lakes Dredge & Dock Corporation is the largest provider of dredging services in the United States. In addition, Great Lakes is fully engaged in expanding its core business into the rapidly developing offshore wind energy industry. The Company has a long history of performing significant international projects. The Company employs experienced civil, ocean and mechanical engineering staff in its estimating, production and project management functions. In its over 131-year history, the Company has never failed to complete a marine project. Great Lakes owns and operates the largest and most diverse fleet in the U.S. dredging industry, comprised of approximately 200 specialized vessels. Great Lakes has a disciplined training program for engineers that ensures experienced-based performance as they advance through Company operations. The Company’s Incident-and Injury-Free® (IIF®) safety management program is integrated into all aspects of the Company’s culture. The Company’s commitment to the IIF® culture promotes a work environment where employee safety is paramount.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Corrected Model. An incorrect Income Statement model was attached to our second quarter update entitled “When It Rains…” and published August 3, 2022. A corrected version is attached. The error involves our full year 2022 revenue and adjusted EBITDA. The correct numbers are $692.8 million and $89.5 million, respectively, compared to $751.4 million and $89.9 million, respectively, in the prior consolidated income statement. The quarterly information is correct. Throughout the report we reference the correct $692.8 million revenue number. In certain instances, we do reference the incorrect $89.9 million adjusted EBITDA number but the de minimis difference between the two figures does not impact our investment case or valuation of GLDD shares.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

E.W. Scripps (SSP) – Strong Political Saves The Day

Monday, August 08, 2022

E.W. Scripps (SSP)
Strong Political Saves The Day

The E.W. Scripps Company (NASDAQ: SSP) is a diversified media company focused on creating a better-informed world. As one of the nation’s largest local TV broadcasters, Scripps serves communities with quality, objective local journalism and operates a portfolio of 61 stations in 41 markets. The Scripps Networks reach nearly every American through the national news outlets Court TV and Newsy and popular entertainment brands ION, Bounce, Defy TV, Grit, ION Mystery, Laff and TrueReal. Scripps is the nation’s largest holder of broadcast spectrum. Scripps runs an award-winning investigative reporting newsroom in Washington, D.C., and is the longtime steward of the Scripps National Spelling Bee. Founded in 1878, Scripps has held for decades to the motto, “Give light and the people will find their own way.”

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

In line Q2 results. The second quarter results were roughly in line with our estimates with revenues of $594.5 million versus our estimate of $603.0 million and adj. EBITDA of $140.2 million versus our estimate of $139.3 million. The biggest variance to our estimates was in the Scripps Networks business, which was adversely affected by weakened National and Direct Response advertising. 

Q3 guide is lower than our estimates, but not horrible. We are lowering our Q3 revenue estimate from $662.0 million to $638.5 million, which reflects 15% growth over the prior year comparable period. We are lowering our Q3 adj. EBITDA estimate from $207.5 million to $170.5 million. The revision reflects soft National advertising in its Networks business and weak Core advertising. The company should cycle to moderate expenses in its Network business in Q4. …

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Energy Fuels (UUUU) – More signs that production is getting closer to ramping up

Monday, August 08, 2022

Energy Fuels (UUUU)
More signs that production is getting closer to ramping up

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. Energy Fuels also produces vanadium from certain of its projects, as market conditions warrant, and is ramping up commercial-scale production of REE carbonate. Its corporate offices are in Lakewood, Colorado, near Denver, and all its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant, as well as REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the Company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” Energy Fuels’ website is www.energyfuels.com.

Michael Heim, CFA, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Energy Fuels reported 2022-2Q results in line with expectations, absent mark-to-market losses. The company reported a loss of $18.1 million or $0.11 per share. However, that included a $13.4 million negative mark to market of the value of investments. Absent that charge, adjusted net income would have been a loss of $4.7 million, or $0.03 per share, vs. our forecast for a loss of $8.6 million, or $0.06 per share.

Vanadium and Rare Earth Element (RRE) sales are modest but poised to expand. The company sold 575,000 lbs. of vanadium, almost twice our forecast at an average price of $13.44/lb. Pricing has dropped so the company has discontinued sales. UUUU sold 205 tonnes of RRE, in line with expectations and pricing. Energy Fuels continues to make strides towards assuring RRE supply and developing circuits to separate heavy and light RRE at its White Mesa facilities….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.